Runway Growth Finance Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Runway Growth Finance Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.05M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $73.61M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $44.34M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $32.25M | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | $45.62M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $46.98M | Mar 2, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $186.31M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $69.76M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $112.44M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | ($359.85M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | ($61.25M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | ($106.09M) | Mar 2, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $960.11M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.09B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.08B | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.14B | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $738.35M | Mar 2, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $475.15M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $576.49M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $532.08M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $565.71M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $132.15M | Mar 2, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $484.97M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $514.87M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $547.07M | Mar 12, 2026 |
| FY2025 | Dec 31, 2022 | $576.05M | Mar 12, 2026 |
| FY2024 | Dec 31, 2021 | $606.20M | Mar 20, 2025 |
| FY2023 | Dec 31, 2020 | $466.24M | Mar 7, 2024 |
| FY2022 | Dec 31, 2019 | $376.31M | Mar 2, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($49.90M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($43.50M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($47.64M) | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | ($19.32M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($267.0K) | Mar 2, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.18M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $5.75M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.97M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $5.76M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $4.70M | Mar 2, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $435.34M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $552.33M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $510.08M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $548.96M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $79.49M | Mar 2, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 2, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 2, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36.13M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 37.35M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 40.51M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 40.51M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 41.38M | Mar 2, 2023 |